Search research articles
Contact Us
Filters
Showing results (71-80 of 111) with videos related to
Page
of 12
Sort By:
Nature Medicine
|
February 7, 2017
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B
Paola Fisicaro, Valeria Barili, Barbara Montanini, et al.
Plos One
|
March 11, 2011
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms
Martin Lagging, Galia Askarieh, Francesco Negro, et al.
The Journal of Infectious Diseases
|
September 9, 2006
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection
Ana I Romero, Martin Lagging, Johan Westin, et al.
Plos One
|
February 26, 2013
Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection
Jonas Söderholm, Jesper Waldenström, Galia Askarieh, et al.
Journal of Hepatology
|
November 14, 2020
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B
Greta Acerbi, Ilaria Montali, Gennaro Domenico Ferrigno, et al.
Hepatology (Baltimore, Md.)
|
November 30, 2006
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
Martin Lagging, Ana I Romero, Johan Westin, et al.
Cancer
|
April 12, 2014
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use
Edoardo G Giannini, Giorgio Sammito, Fabio Farinati, et al.
Gastroenterology
|
October 9, 2007
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project)
Massimo Pilli, Alessandro Zerbini, Amalia Penna, et al.
JHEP Reports : Innovation in Hepatology
|
February 18, 2026
Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis B
Marzia Rossi, Andrea Vecchi, Camilla Tiezzi, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2023
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016)
Benedetta Pellegrino, Chiara Tommasi, Olga Serra, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 111) with videos related to
Sort By:
Page
of 12
Nature Medicine
|
February 7, 2017
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B
Paola Fisicaro, Valeria Barili, Barbara Montanini, et al.
Plos One
|
March 11, 2011
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms
Martin Lagging, Galia Askarieh, Francesco Negro, et al.
The Journal of Infectious Diseases
|
September 9, 2006
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection
Ana I Romero, Martin Lagging, Johan Westin, et al.
Plos One
|
February 26, 2013
Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection
Jonas Söderholm, Jesper Waldenström, Galia Askarieh, et al.
Journal of Hepatology
|
November 14, 2020
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B
Greta Acerbi, Ilaria Montali, Gennaro Domenico Ferrigno, et al.
Hepatology (Baltimore, Md.)
|
November 30, 2006
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
Martin Lagging, Ana I Romero, Johan Westin, et al.
Cancer
|
April 12, 2014
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use
Edoardo G Giannini, Giorgio Sammito, Fabio Farinati, et al.
Gastroenterology
|
October 9, 2007
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project)
Massimo Pilli, Alessandro Zerbini, Amalia Penna, et al.
JHEP Reports : Innovation in Hepatology
|
February 18, 2026
Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis B
Marzia Rossi, Andrea Vecchi, Camilla Tiezzi, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2023
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016)
Benedetta Pellegrino, Chiara Tommasi, Olga Serra, et al.
Page
of 12